dr. herbst on the next generation of lung cancer trials
Published 9 years ago • 284 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:01
dr. herbst on the international lung cancer congress
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:42
dr. herbst on a smoking cessation trial for lung cancer
-
1:11
dr. herbst on screening studies at the upcoming lung cancer congress
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
1:12
dr. roy herbst on the emergence of immunotherapy in cancer
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
1:23
dr. herbst on themes from the 2011 lung cancer congress
-
2:02
dr. herbst on the development of biomarkers for lung cancer
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
2:29
dr. herbst discusses the state of immunotherapy in lung cancer
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer